METHODS: The study was performed among 18 individuals with self-reported asthma symptoms. Asthma symptoms were recorded on a 0 (minimum)-4 (maximum) point scale at baseline and at 4 weeks with elements including daily puffs of inhaler, sleep quality, interference with daily activities and control of asthma as per the ATAQ scale.
RESULTS: 16/18 individuals (89%) provided all survey data at baseline and at 4 weeks. There was a statistically significant change in asthma symptoms from baseline to those seen at four weeks (2.06 at baseline and 0.75 post intervention) resulting in a mean difference of 1.31(95% CI 0.45 to 2.18; p=0.006).
CONCLUSIONS: With the use of PECO air purification technology, self reported asthma scores decreased significantly. Future studies with increased patient numbers and objective asthma endpoints are planned to confirm these findings.